Aim: Paracrine interaction between macrophages and adipocytes in obese visceral fat tissues is thought to be a trigger of chronic inflammation. The immunomodulatory effect of the short chain fatty acid, butyric acid, has been demonstrated. We hypothesize that sodium butyrate (butyrate) attenuates inflammatory responses and lipolysis generated by the interaction of macrophages and adipocytes. Methods: Using contact or transwell co-culture methods with differentiated 3T3-L1 adipocytes and RAW264.7 macrophages, we investigated the effects of butyrate on the production of tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein 1 (MCP-1), interleukin 6 (IL-6), and the release of free glycerol, free fatty acids (FFAs) into the medium. We also examined the activity of nuclear factor-kappaB (NF-κB) and the phosphorylation of mitogen-activated protein kinases (MAPKs) in co-cultured macrophages, as well as lipase activity and expression in co-cultured adipocytes. Results: We found increased production of TNF-α, MCP-1, IL-6, and free glycerol, FFAs in the coculture medium, and butyrate significantly reduced them. Butyrate inhibited the phosphorylation of MAPKs, the activity of NF-κB in co-cultured macrophages, and suppressed lipase activity in co-cultured adipocytes. Lipase inhibitors significantly attenuated the production of TNF-α, MCP-1 and IL-6 in the co-culture medium as effectively as butyrate. Butyrate suppressed the protein production of adipose triglyceride lipase, hormone sensitive lipase, and fatty acid-binding protein 4 in co-cultured adipocytes. Pertussis toxin, which is known to block GPR41 completely, inhibited the antilipolysis effect of butyrate. Conclusion: Butyrate suppresses inflammatory responses generated by the interaction of adipocytes and macrophages through reduced lipolysis and inhibition of inflammatory signaling. 
Introduction
crine loop of free fatty acids (FFAs) derived from adipocytes, and monocyte chemoattractant protein 1 (MCP-1) and tumor necrosis factor-alpha (TNF-α) from macrophages acts in a vicious cycle 6) . Monocytes are thought to migrate from the peripheral blood stream to adipose tissues using these cytokines, becoming activated macrophages that produce various substrates and promote inflammation around adipose tissue 7) . Many investigators have observed the accumulation of macrophages in adipose tissue, as well as the increased gene expression of inflammatory mediators, such as TNF-α, interleukin 6 (IL-6) and inducible nitric oxide synthase (iNOS), in humans and animal models of obesity 8, 9) . Short chain fatty acids (SCFAs), such as acetic acid, propionic acid and butyric acid, are produced by anaerobic bacterial fermentation of undigested carbohydrates in the colon 10) , and are rapidly absorbed to provide energy for the colorectal epithelium, and are increased in rectal mucosal blood flow 11) . Of these, sodium butyrate (butyrate) was reported to have antiinflammatory effects in the colon 12) by modulating IL-8 13) and macrophage inflammatory protein 2 activities 14) . With respect to the underlying mechanism, butyrate is known to prevent the degradation of inhibitor kappaB-alpha (IκB-α) and to regulate the production of inflammatory mediators 15, 16) . A recent study revealed that oral administration of tributyrin (a prodrug of butyrate) attenuated endotoxin-induced hepatic injury via downregulation of Toll-like receptor 2 (TLR2), TNF-α and nuclear factor-kappaB (NF-κB) 17) . Since SCFA receptors, such as G protein coupled receptor 41 or 43 (GPR41, 43) , are highly expressed in both adipocytes and macrophages 18, 19) , butyrate may have synergistic effects on both cell types. In addition, it is reported that FFAs act as ligands for Toll-like receptor 4 (TLR4), which plays an important role in the inflammatory response and is highly expressed in macrophages 20, 21) . These findings indicate that butyrate might be applicable for its physiological and pharmacological effects 22) . For instance, Gao et al. reported improved insulin resistance by long-term ingestion of sodium butyrate in obese mice 23) . Vinolo et al. also reported that oral administration of tributyrin improved obesity-associated inflammation in mice fed a high-fat diet 24) ; however, the effect of butyrate on the mutual inflammatory response in adipocytes and macrophages has not yet been elucidated.
In the present study, we investigated the effects of butyrate on the production of pro-inflammatory mediators in the interaction between macrophages and adipocytes, and determined the underlying mech-10 sec, 60 ℃ for 10 sec, and 72 ℃ for 10-20 sec. Primers for the different genes are listed in Table 1 . In determining the targeted mRNA levels, the level of GAPDH mRNA was adopted as the internal standard.
Nitrite/Nitrate Quantification
The amount of nitrite/nitrate in the culture medium was measured using the Griess method 25) . Co-culture was performed using the transwell method. Serum-starved differentiated 3T3-L1 (5.0×10 5 cells/ well) were cultured in the lower chamber of a 24-well Transwell plate, and RAW264.7 (5.0×10
5 cells/well) in the upper chamber were plated in serum-free HAM's F12 medium.
The cells were cultured for 24 h in the presence of butyrate (0, 0.1, 0.2, 0.5, 1.0 mmol/L) and the culture medium was harvested. nitric oxide (NO) production from the media was determined by measuring the amount of nitrite/nitrate (NO2 − /NO3 − ), a stable oxidation end product of NO, using a NO2
− Assay Kit-C2 (DOJINDO Laboratories, Kumamoto, Japan).
Western Blotting
Co-culture was performed using the transwell method. Protein was extracted from RAW264.7 in the upper chamber and from 3T3-L1 in the lower chamber. For Western blot analysis, RAW264.7 or 3T3-L1 were lysed in M-PER Mammalian Protein Extraction reagent (Pierce, Rockford, IL) with a protease inhibitor, and phosphatase inhibitor cocktail (Nacalai Tesque). Protein concentration was determined using protein assay reagent (Bio-Rad Laboratories, Hercules, CA). Denatured proteins were separated using SDSpolyacrylamide gel electrophoresis on a 10% polyacrylamide gel and then transferred onto Immobilon-P membranes (Millipore, Billerica, MA). We used rabbit anti-mouse iNOS type 2 (1:1000; BD Biosciences, Franklin Lakes, NJ), rabbit anti-mouse inhibitor κB-α (IκB-α) antibody and rabbit anti-mouse phospho-IκB-α antibody (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-mouse phospho-p38 mitogenstarved RAW264.7 (5.0×10 5 cells/well). After incubation with butyrate (0, 0.1, 0.2, 0.5, 1.0 mmol/L) in 2% FFA-free BSA for 24 h, RAW264.7 in the upper chamber were harvested. In some experiments, the medium supernatants or cell lysate solutions of differentiated 3T3-L1 and RAW264.7 were used to harvest the co-cultures.
Measurement of TNF-α, IL-6 and MCP-1 Proteins
The concentrations of TNF-α, IL-6 and MCP-1 in the culture medium were determined by ELISA, conducted using a READY-SET-GO Mouse TNF-α, IL-6 kit (eBioscience, San Diego, CA), and Mouse MCP-1 Screening Set (Thermo Scientific, Waltham, MA) in accordance with the manufacturer's instructions. Secretion levels in individual RAW264.7 and 3T3-L1 single cultures were determined as controls.
Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR)
Total RNA was extracted from the Transwell plate's upper chamber of RAW264.7 and lower chamber of 3T3-L1 using TRIzol reagent (Invitrogen, Carlsbad, CA). Single-stranded cDNA was synthesized from 1 μg total RNA using a ReverTra Ace-α, first-strand cDNA synthesis kit (Toyobo, Osaka, Japan). Incubation was carried out at 37 ℃ for 60 min. The temperature of the reaction was then raised to 94 ℃ for 5 min in order to inactivate the enzyme and was then reduced to 4 ℃, using a thermal cycler Gene Amp PCR System 9700 (Applied Biosystems, Carlsbad, CA).
To quantitate mRNA expression, qRT-PCR was performed using a LightCycler System (Roche Diagnostics, Mannheim, Germany) and LightCycler Fast Start DNA Master Plus SYBR Green 1 (Roche Diagnostics). The linearity of amplification was determined for TNF-α, IL-6, MCP-1 and GAPDH cDNA from each cell type, and fatty acid-binding protein 4 (FABP4) from 3T3-L1.
The qRT-PCR program was 45 cycles at 95 ℃ for ACACTCAGATCATCTTCTCAAAATTCG  ATGCAGGTCCCTGTCATGCTTC  AACGATGATGCACTTGCAGA  TCACCTGGAAGACAGCTCCT  CATCACCATCTTCCAGGAGCG   GTGTGGGTGAGGAGCACGTAGT  GGCATCACAGTCCGAGTCACAC  GAGCATTGGAAATTGGGGTA  AATCCCCATTTACGCTGATG  GAGGGGCCATCCACAGTCTTC   X02611  BC145869  X54542  BC054426  M32599 TNF-α: tumor necrosis factor alpha, MCP-1: monocyte chemoattractant protein 1, IL-6: interleukin 6, FABP4: fatty acid-binding protein 4, GAPDH: glyceraldehyde-3-phosphate dehydrogenase method. Protein was extracted from 3T3-L1 in the Transwell plate lower chamber. 3T3-L1 were lysed in M-PER Mammalian Protein Extraction reagent with a protease inhibitor cocktail. Protein concentration was determined using protein assay reagent (Bio-Rad Laboratories). Lipase activity was determined using a Lipase Activity Assay Kit 2 (Biovision), according to the manufacturer's instructions.
Fatty Acid Composition Comparative Analysis
Co-culture was performed using the contact method. Serum-starved differentiated 3T3-L1 (5.0× 10 5 cells/well) were cultured in a 24-well plate, and RAW264.7 (2.0×10 5 cells/well) were plated onto the 3T3-L1 in DMEM with 2% FFA-free BSA. After butyrate treatment with the co-culture medium, the composition of FFAs was analyzed with the UHPLC-MS/MS system (Ultra high performance liquid chromatography, Nexera; MS: LCMS-8030 triple quadrupole mass spectrometry, Shimadzu Co., Kyoto, Japan) controlled by LabSolutions LCMS version 5.4 (Shimadzu Co.). To perform the relative concentration assessment, the peak area values obtained from the MRM chromatogram of each fatty acid were normalized using that of C19:0 tuberculostearic acid as an internal standard. Next, the amounts of each fatty acid in the co-culture medium, with and without butyrate treatment, were calculated, subtracting the results of each negative control sample from those of the corresponding co-culture sample.
Palmitate Treatment
Palmitate stock solutions containing 2% FFAfree BSA were prepared in serum-free DMEM immediately before the experiment. RAW 264.7 were treated with 200, 500 μmol/L palmitate, and 0, 0.1, 0.2, 0.5, 1.0 mmol/L butyrate for 24 h. A solution of 2% FFA-free BSA alone was used as the control. The concentrations of TNF-α, IL-6, and MCP-1 in the culture medium were determined by ELISA.
Effects of Lipase Inhibitors on TNF-α, IL-6, and MCP-1 3T3-L1 were pretreated for 1 h with 0.5% (v/v) DMSO alone (vehicle), 10 μmol/L, 100 μmol/L orlistat (lipase inhibitor; Cayman Chemical) or 2 μmol/L, 20 μmol/L CAY10499 (hormone-sensitive lipase inhibitor; Cayman Chemical) dissolved in DMSO, and diluted in serum-free DMEM with 2% FFA-free. Next, the cells were co-cultured (contact method) with RAW264.7 for 24 h. The concentrations of TNF-α, IL-6 and MCP-1 in the culture medium were determined by ELISA. activated protein kinase (MAPK) antibody, rabbit antimouse p38 antibody, rabbit anti-mouse phospho-c-Jun N-terminal kinase (JNK) antibody, rabbit anti-mouse JNK antibody, rabbit anti-mouse phospho extracellular signal-regulated kinase1/2 (ERK1/2) antibody, rabbit anti-mouse ERK1/2 antibody (1:2000; R&D Systems), rabbit anti-mouse adipose triglyceride lipase (ATGL) antibody, rabbit anti-mouse hormone-sensitive lipase (HSL) antibody (1:1000; Cayman Chemical), rabbit anti-mouse phospho-HSL (Ser660) antibody (1:1000; Cell Signaling Technology, Danvers, MA), rabbit anti-mouse actin (1:1000; Santa Cruz), anti-rabbit antibody horseradish peroxidase-linked immunoglobulin G (IgG) antibodies (1:2000; GE Healthcare, Buckinghamshire, UK). The blots were developed using ECL (GE Healthcare). Relative protein expression levels were determined by dividing the band intensity of the product of interest by that of the corresponding actin band.
NF-κB p65 Activation Assay
Nuclear protein was extracted from RAW264.7 in the upper chamber of the Transwell plate. Cell lysate protein was harvested 6 h after co-culture treatment with butyrate, and nuclear extracts (2 μg) were assayed in triplicate for p65 activity with a TransAM NF-κB p65 transcription factor assay kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions.
Lipolysis Assay
Co-culture was performed using the transwell method. Differentiated 3T3-L1 were incubated overnight in serum-free DMEM with 2% FFA-free BSA. Next, 3T3-L1 were co-cultured with RAW264.7 in serum-free DMEM with 2% FFA-free BSA. The cells were cultured for 24 h with butyrate (0, 0.1, 0.2, 0.5, 1.0 mmol/L), and the culture medium was harvested. In addition, 3T3-L1 were stimulated by the addition of TNF-α (10 ng/mL), the cells were cultured for 24 h with butyrate, and the culture medium was then harvested.
The levels of FFA in the co-culture medium were measured using an acyl-coenzyme A oxidase-based colorimetric assay method 26) ; C-8 (octane) and longer fatty acids can be detected in this assay. The concentrations of FFAs and free glycerol in the medium were measured using a Free Fatty Acid Quantification Kit (Biovision, Milpitas, CA) and Adipolysis Assay kit (Cayman Chemical), respectively.
3T3-L1 Total Lipase Assay
Co-culture was performed using the transwell in the medium, although the peak values were lower than those observed in the contact method. Butyrate significantly and dose-dependently reduced these concentrations. In 3T3-L1 ( Fig. 2A, B , and C) and RAW264.7 ( Fig. 2D , E, and F) cultured using the transwell method, we also confirmed that the mRNA expression of TNF-α, MCP-1, and IL-6 was elevated. Butyrate dose-dependently and significantly suppressed the mRNA expression of TNF-α, MCP-1, and IL-6 in each cell type ( Fig. 2A-F) .
Effect of Butyrate on NF-κB Transcription Activity and MAPK Phosphorylation in Co-Cultured Macrophages
To clarify the mechanism by which butyrate inhibits the inflammatory response in the transwell method, we investigated the degradation and phosphorylation of IκB-α and the phosphorylation of MAPKs in RAW264.7.
Marked degradation and phosphorylation of IκB-α were observed in RAW264.7 cultured for 6 h using the transwell method, and butyrate dose-dependently inhibited IκB-α degradation and phosphorylation (Fig. 3A) . Furthermore, we examined NF-κB p65 transcription activity in RAW264.7 treated with butyrate using the transwell method. Consistent with IκB-α observations, marked elevation of NF-κB transcriptional activity in RAW264.7 was observed (data not shown). Similarly, activation of NF-κB p65 was significantly reduced in RAW264.7 by treatment with ≥ 0.2 mmol/L butyrate (Fig. 3B) .
We also investigated the signaling pathway upstream of NF-κB transcription in RAW264.7. Phosphorylation of p38, ERK1/2, and JNK1/2 was enhanced by co-culture using the transwell method, with butyrate dose-dependently reducing their phosphorylation (Fig. 3C) .
Effect of Butyrate on Nitrite/Nitrate Production in Co-Cultured Macrophages
To elucidate the effect of butyrate on an additional macrophage inflammatory response, we investigated the production of NO using the transwell method. NO2
− levels were elevated in the coculture medium compared to separate cultures. Butyrate significantly and dose-dependently reduced NO2
− production (Fig. 4A) . We also showed that butyrate dose-dependently reduced iNOS protein expression in co-cultured macrophages (Fig. 4B) . These results suggest that co-culture accelerates inflammation, and that butyrate reduces the production of inflammatory mediators in macrophages.
Measurement of Fatty Acid-Binding Protein 4 (FABP4)
The concentration of FABP4 in the contact method culture medium was determined by ELISA, which was conducted using a Rat/Mouse FABP-4 ELISA Kit (Adipo Bioscience, Santa Clara, CA) in accordance with the manufacturer's instructions. Secretion levels in RAW264.7 and 3T3-L1 single cultures were determined as controls.
Effect of Pertussis Toxin (PTX) on Lipolysis and TNF-α, IL-6, MCP-1 Levels
3T3-L1 were pretreated for 1 h with 10 ng/mL PTX, which was dissolved in sterile distilled water and diluted in serum-free DMEM with 2% FFA-free BSA. Next, the cells were co-cultured with RAW264.7 and 0, 0.2, 0.5, 1.0 mmol/L butyrate for 24 h using the contact method. The concentrations of FFAs and free glycerol in the medium were measured using the above-mentioned methods. The concentrations of TNF-α, IL-6 and MCP-1 in the culture medium were determined by ELISA.
Statistical Analysis
Data were assessed using ANOVA with TukeyKramer post-hoc comparisons, and are expressed as the mean±SD. For fatty acid composition analysis, co-culture and butyrate treatment were compared using a paired t -test. Statistical analysis was performed using GraphPad Prism ver 5.0 (GraphPad Software Inc., San Diego, CA). Two-tailed values of p＜0.05 were used to indicate statistical significance.
Results

Effect of Butyrate on the Expression of TNF-α, MCP-1, and IL-6 Protein and mRNA in Co-Culture Medium
Preliminary experiments confirmed that 24 h incubation of RAW264.7 with ＞2.0 mmol/L butyrate resulted in excessive toxicity using the MTT assay (data not shown); therefore, ＜2.0 mmol/L butyrate was used in all subsequent experiments. Protein concentrations of TNF-α, MCP-1, and IL-6 in the culture medium in differentiated 3T3-L1 or RAW264.7 were very low when cultured separately (Fig. 1A, B , and C). However, these concentrations were markedly elevated in the medium of cells cultured using the contact method, and were significantly and dosedependently reduced by butyrate treatment. We also confirmed these elevations using the transwell method. As shown in Fig. 1D , E, and F, protein concentrations of TNF-α, MCP-1, and IL-6 were markedly elevated examine whether inflammatory mediators regulate lipolysis, we treated 3T3-L1 with 10 ng/mL recombinant TNF-α. TNF-α significantly increased the release of FFAs and free glycerol, which was markedly suppressed by the anti-TNF-α neutralizing antibody. As expected, butyrate dose-dependently reduced the release of FFAs and free glycerol from 3T3-L1 treated with TNF-α (Fig. 5C, D) .
Effect of Butyrate on Lipolysis in Co-Cultured Adipocytes
To elucidate the underlying mechanism of coculture-induced inflammation, we investigated whether co-culture modulates lipolysis, as well as the effect of butyrate. The release of FFAs and free glycerol was significantly elevated in the transwell method medium. Butyrate (≥ 0.2 mmol/L) significantly reduced the release of FFAs and free glycerol (Fig. 5A, B) . To palmitate (C16:0) treatment on RAW264.7, as palmitate is known to have pro-inflammatory effects on macrophages 21, 27) . The addition of palmitate significantly elevated TNF-α, MCP-1, and IL-6 protein concentrations in the culture medium, which were reduced by butyrate in a dose-dependent manner (Fig. 6B, C, and D) .
Effect of Butyrate on Lipase Activity and Protein Expression in Co-Cultured Adipocytes
Lipase activity was significantly elevated in adipocytes co-cultured using the transwell method (142.3%±14.8% vs. the control). Butyrate (≥ 0.5
Effect of Butyrate on Fatty Acid Composition in Co-Culture Medium
Levels of specific FFAs in the contact method medium were determined before and after the addition of 0.5 mmol/L butyrate. Relative peak area of the following fatty acids was decreased with butyrate administration: C14:0 myristic acid, C16:0 palmitic acid, C16:1 (n-7) palmitoleic acid, C18:2 (n-6) linoleic acid, and C18:1 (n-9) oleic acid (Fig. 6A) . Specifically, the main FFAs: C16:0, C16:1(n-7), C18:1 (n-9) were significantly reduced.
To confirm whether FFAs induce inflammatory responses in macrophages, we examined the effect of 3 . Effect of butyrate on IκB-α phosphorylation and degradation in RAW264.7 co-cultured for 6 h using the transwell method. Protein expression of phosphorylated and unphosphorylated IκB-α, and actin was detected by Western blotting (A). Effect of butyrate on NF-κB p65 activity induced by 6 h co-culture using the transwell method (B). NF-κB p65 activity in RAW264.7 was measured as described in Materials and Methods. As a control, NF-κB p65 activity was measured in nonco-cultured RAW264.7. Values from five independent experiments are expressed as the mean±SD. 
Effect of Butyrate on FABP4 Protein and Gene Expression in Co-Cultured Adipocytes
We examined FABP4 protein and mRNA expression and found that FABP4 protein concentrations were elevated in the contact method co-culture medium compared to separate cultures (Fig. 9A) . Butyrate treatment dose-dependently inhibited the expression of FABP4 protein in co-cultured adipocytes. Furthermore, the expression of FABP4 mRNA was markedly elevated in adipocytes in the transwell method, and butyrate treatment inhibited this elevation (Fig. 9B) .
Effect of Pertussis Toxin (PTX) on Lipolysis and TNF-α, IL-6, MCP-1 Levels in Co-Culture Medium
It has been reported that two GPCRs (GPR41 and GPR43) have an affinity for SCFAs, and that PTX, known to inactive Gi proteins, negates the response of GPR41 but not of GPR43 28) . GPR41 is predominantly expressed in adipose tissue, while GPR43 is expressed in immune cells 18) . To further examine butyrate's mechanism of action, we investigated whether PTX influences the anti-lipolytic effects mmol/L) significantly reduced lipase activity in adipocytes (Fig. 7A) .
Next, we confirmed that butyrate dose-dependently reduced the protein expression of ATGL, HSL, and phospho-HSL (Ser660) in co-cultured adipocytes (Fig. 7B) . These results suggest that butyrate can inhibit lipolysis by suppressing lipase protein production and phosphorylation in co-cultured adipocytes.
Effects of Lipase Inhibitors on TNF-α, IL-6 and MCP-1 Levels in Co-Culture Medium
To further understand the role of lipolysis in the inflammatory response, we examined the effects of orlistat (lipase inhibitor) and CAY10499 (hormonesensitive lipase inhibitor) on the production of inflammatory cytokines using the contact method. Treatment with orlistat or CAY10499 significantly reduced TNF-α, MCP-1, and IL-6 protein concentrations in the medium (Fig. 8A, B, and C) . These reductions were similar to the effect of 0.5 mmol/L butyrate. Fig. 4 . Effect of butyrate on NO production in 24 h co-culture medium using the transwell method (A). NO2-/NO3-levels in the medium were measured by the Griess method. As controls, we measured these concentrations in the medium of non-co-cultured 3T3-L1 or RAW264.7. Values from five independent experiments are expressed as the mean±SD.
＊ ＊ ＊ p＜0.001 versus co-culture by ANOVA and the Tukey-Kramer method. Effect of butyrate on iNOS expression in RAW264.7 co-cultured for 24 h using the transwell method. Protein expression and actin were detected by Western blotting (B). First, we confirmed that the co-culture of adipocytes and macrophages results in marked up-regulation of the expression of pro-inflammatory mediators (mRNA and proteins), including TNF-α, MCP-1, IL-6, and the release of FFAs. These results are consistent with previous reports 6, 30) . To separately analyze macrophages and adipocytes, we compared cytokine and FFA production using both contact and transwell methods. Suganami et al. indicated that co-culture upregulation of TNF-α was mainly derived from macrophages, while that of MCP-1 was mainly derived from adipocytes 6) . Our results also showed that the expression of MCP-1 mRNA in adipocytes and TNF-α mRNA in macrophages was higher than in cells cocultured with the transwell method. With respect to the observed differences in MCP-1 levels between the contact and transwell methods, we speculate that 3T3-L1 cells in the contact method were directly and of butyrate in 3T3-L1 and the anti-inflammatory effects in RAW264.7. PTX is known to increase cyclic adenosine monophosphate (cAMP) in fat cells, which may induce lipolysis 29) . The release of FFAs and free glycerol was elevated with 10 ng/mL PTX treatment in co-culture medium. Moreover, we found that treatment with PTX completely blocked the anti-lipolysis effect of butyrate (Fig. 10A, B) . Correspondingly, PTX elevated TNF-α, MCP-1 and IL-6 protein concentrations in co-culture medium, and PTX partially blocked the inhibitory effect of butyrate for TNF-α, MCP-1, IL-6 production (Fig. 10C, D, and E) .
Discussion
In this study, we demonstrated the inhibitory effects of butyrate on inflammation and lipolysis in the interaction between macrophages and adipocytes. . Cell to cell contact may influence MCP-1 production via such a substrate or others.
Next, we reported the novel observation that butyrate suppressed the co-culture-induced up-regulation of TNF-α, MCP-1, IL-6, FFAs, iNOS, and NO in a dose-dependent manner, suggesting that butyrate can suppress both the macrophage inflammatory pathclosely activated by the high concentration of inflammatory factors proximal to macrophages, as opposed to the transwell method. A recent report demonstrated that apoptosis inhibitor of macrophages (AIM), which is highly expressed by foam macrophages and inhibits apoptosis of these cells, induced the degradation of IκB-α, MCP-1 gene expression and lipolysis in TNF-α in 3T3-L1 significantly induced the release of FFAs and free glycerol, probably derived from the lipolysis of triglycerides in adipocytes, which was confirmed by the elevation in total lipase activity (Fig. 7A) , and ATGL, HSL, and phospho-HSL (Ser660) expression (Fig. 7B) . Butyrate significantly reduced the release of FFAs and glycerol, and inhibited total lipase activity and the expression of ATGL, HSL, phospho-HSL (Ser660) in co-cultured adipocytes. Interestingly, the inhibitory effects of butyrate on the inflammatory response were similar to those observed with the lipase inhibitor orlistat or CAY10499 (Fig. 8) , which suggests that HSL activity way and the adipocyte lipolysis pathway. Thus, we sought to investigate butyrate's underlying mechanism of action.
Fatty acids are stored as triacylglycerol in adipocytes and their sequential hydrolysis results in the release of FFAs, along with the generation of diacylglycerol, monoacylglycerol, and glycerol 32) . Several lipases, such as ATGL and HSL, are involved in lipolysis 33) . Glycerol cannot be utilized for triacylglycerol resynthesis due to the lack of glycerol kinase in normal adipocytes, and is therefore released along with FFAs into the culture medium 34) . In this study, we demonstrated that co-culture or the addition of recombinant Fig. 7 . Effect of butyrate on total lipase activity in 3T3-L1 co-cultured for 24 h using the transwell method (A). Lipase activity levels were measured using an assay kit, as described in Materials and Methods. As a control, activity was measured in non-cocultured 3T3-L1. Values from five independent experiments are expressed as the mean±SD. signaling pathways in macrophages and the production of pro-inflammatory mediators, and demonstrated that butyrate suppressed these signaling pathways. Moreover, we analyzed FFA composition in the medium and found that major FFAs (myristic, palmitic, palmitoleic, linoleic, and oleic acids) were similarly reduced after butyrate treatment, although we could not specify which FFA(s) released from adipois the main contributor to the co-culture-induced inflammatory response. A previous report revealed that FFAs, specifically saturated FFAs such as palmitic acid, can exert proinflammatory effects on macrophages through the activation of TLR4 and the MAPK pathway, involving p38, ERK1/2, JNK1/2, and IκB/NF-κB 21, 27) . Consistent with this, we confirmed the activation of these macrophages results in marked up-regulation of FABP4 in the medium, which butyrate significantly reduced. Although we cannot explain the mechanism by which co-culture up-regulates the expression of FABP4, it may be one of the initial steps in the interaction of adipocytes and macrophages. It has been reported that GPR41 and 43 have an affinity for SCFAs 18, 19) . Acetate and propionate stimulate adipogenesis, upregulate PPAR-γ2 and inhibit isoproterenol-induced lipolysis via GPR43 in 3T3-L1 19) . In addition, leptin is increased via SCFA stimucytes induced the inflammatory response. Next, we confirmed that palmitate significantly elevated protein concentrations of TNF-α, MCP-1, and IL-6 in the culture medium, which were reduced by butyrate in a dose-dependent manner. Recent reports showed that up-regulation of FABP, especially FABP4, induces lipolysis in adipocytes, inflammatory responses in macrophages, as well as insulin resistance and atherosclerosis 35) . Jenkins-Kruchten et al. demonstrated that FABP4 binds to HSL and up-regulates its activity 36) . We demonstrated that co-culture of adipocytes and Inflammatory leucocytes, including T-lymphocytes, were also reported to infiltrate visceral adipose tissues, which may contribute to local adipose tissue inflammation and insulin resistance in obese mice 40) . A low concentration of butyrate was reported to inhibit the proliferation of T-lymphocytes, and to induce apoptosis in activated T-lymphocytes, but not primary macrophages 41) . In the adipose tissue of obese mice, butyrate decreased infiltration by leukocytes 24) . Therefore, butyrate might contribute to the attenuation of inflammation in obese adipose tissues via the induction of T-cell apoptosis. In high dietary fat obese C57BL/6 mice, butyrate supplementation improved insulin sensitivity 23) . Resistant starches are dietary carbohydrates that resist digestion in the intestine, where they are instead fermented by bacteria, producing SCFAs. A recent report suggests that highly resistant starch diet-associated SCFAs may improve glucose tolerance in diabetic mice 42) . iNOS has emerged as an important player in insulin resistance. Inhibition of iNOS ameliorates obesity-induced insulin resistance. S-nitrosylation is elevated in patients with type 2 diabetes, and increased S-nitrosylation of insulin signaling molecules, including insulin receptor, insulin receptor substrate-1, and Akt/PKB, has been shown in the skeletal muscle of obese, diabetic mice 43) . This, taken together with our results concerning NO, iNOS, and FABP4, indicates that butyrate might have favorable effects on insulin sensitivity by repressing the vicious cycle of adipocyte and macrophage interaction.
In conclusion, butyrate suppresses inflammation generated by the interaction of 3T3-L1 and RAW264.7 by inhibiting inflammatory signals in macrophages and lipolytic activity in adipocytes. Butyrate treatment could be a useful choice for improving metabolic disorders by suppressing the vicious cycle of inflammation in obese visceral adipose tissues.
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This study was supported, in part, by grants for the Global COE Program, Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [M.Y.] and for project research (Development of fundamental technology for analysis and evaluation of functional agricultural products and functional foods) from the Ministry of Agriculture, lation of GPR41 in mouse adipose tissue 37) . We demonstrated that PTX, which is known to block the response of GPR41 but not of GPR43, completely inhibited the anti-lipolysis effect of butyrate, suggesting that butyrate may inhibit lipolysis via GPR41 in 3T3-L1. On the other hand, PTX incompletely blocked the reduction in TNF-α, MCP-1, and IL-6 production by butyrate. This, taken together with a report indicating that monocytes express low levels of GPR41 18) , shows that GPR41 may contribute to the inhibition of lipolysis via Gi protein-mediated signaling in adipocytes, whereas the reduced production of TNF-α, MCP-1, and IL-6 was mediated via GPR41 and other pathways. Further examination is required to reveal the pathway utilized by butyrate, for example, by directly stimulating or inhibiting GPR41 and 43.
Thus, we propose that butyrate suppresses lipolysis in adipocytes, and sequentially suppresses the inflammatory response in macrophages via a signaling pathway involving p38, ERK1/2, JNK1/2, and IκB/ NF-κB. It is also possible that TNF-α, MCP-1, and IL-6 originate from adipocytes via an autocrine mechanism. Conversely, we also acknowledge the possibility that co-culture induces the initial production of inflammatory mediators, followed by lipolysis 6) . On the other hand, we previously demonstrated that butyrate enhances IL-1β production via the activation of oxidative stress pathways in lipopolysaccharidestimulated THP-1 cells 38) . Although the culture condition in the previous study is different from the present study, butyrate appears to have acceleratory or inhibitory effects on the macrophage-mediated inflammatory response. Further studies are necessary to understand the factors that play an initiating role in this vicious cycle.
A significant proportion of acetate and most of the remaining butyrate and propionate are removed from the portal venous system by the liver. Concentrations of butyrate in human peripheral circulation are generally very low, ranging from 1-4 μmol/L 39) , a level insufficient to exert physiological effects, such as inflammatory modulation of immune cells 12, 15) . However, visceral fat is exposed to higher levels of SCFAs in the portal circulation, which can reach 0.45 mmol/ L 37) , although the composition of SCFAs in the portal vein is affected by diet to a greater extent than in the peripheral circulation. To overcome low butyrate levels in animal experiments, tributyrin, a prodrug of butyrate with low toxicity, has been used to increase plasma butyrate levels up to 2.4 mmol/L at 1 h, with levels maintained at 0.7 mmol/L in the portal vein of mice at 2.5 h after oral administration 17) . Thus, the effects
